Suppr超能文献

DYT1 阳性原发性全身性肌张力障碍的深部脑刺激治疗的疾病稳定:15 年随访。

Disease Stabilization of DYT1-Positive Primary Generalized Dystonia With Deep Brain Stimulation of the Globus Pallidus Interna: A 15-Year Follow-up.

机构信息

Department of Neurosurgery, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania.

Drexel University College of Medicine, Philadelphia, Pennsylvania.

出版信息

Oper Neurosurg (Hagerstown). 2018 May 1;14(5):597. doi: 10.1093/ons/opx137.

Abstract

BACKGROUND AND IMPORTANCE

Primary generalized dystonia (PGD) is a genetic form of dystonia that frequently displays pharmacological resistance and progresses quickly after onset. Deep brain stimulation (DBS) has been used successfully to treat refractory dystonia, specifically globus pallidus interna (GPi) DBS for DYT1-positive PGD patients. Long-term follow-up of the safety and efficacy falls short of the longevity seen in other diseases treated with DBS.

CASE PRESENTATION

A male patient presented for neurosurgical evaluation with scapular winging, hand contractures, and violent truncal spasms, which forced him to be bedridden. After failing conservative therapy, the 18-yr-old patient was implanted with bilateral GPi-DBS. DBS parameter adjustments were made primarily within the first 3 yr after implantation, with nominal changes thereafter. Initial settings were contact of 3 + 0-, amplitude of 4.9 V, frequency of 185 Hz, and pulse width of 270 μsec on the left and 3 + 0-, 2.8 V, 185 Hz, and 120 μsec on the right. Current settings are 3 + 2 + 1-, 5.2 V, 130 Hz, 330 μsec on the left and 3 + 0-, 3.5 V, 185 Hz, and 180 μsec on the right and have been relatively unchanged in the past 4 yr. Unified dystonia rating scale scores reveal a significant decrease in dystonic symptoms.

CONCLUSION

While prior reports have shown that GPi-DBS is effective for dystonia, this is the first with 15 yr of long-term follow-up showing disease stabilization, suggesting that stimulation is efficacious and can potentially prevent disease progression. This report reaffirms previous reports that recommend early surgical intervention before the onset of permanent musculoskeletal deficits.

摘要

背景与重要性

原发性全身性肌张力障碍(PGD)是一种遗传性肌张力障碍,常表现出药物抵抗,且发病后迅速进展。深部脑刺激(DBS)已成功用于治疗难治性肌张力障碍,特别是 DYT1 阳性 PGD 患者的苍白球内侧(GPi)DBS。与其他用 DBS 治疗的疾病相比,其长期随访的安全性和有效性都不及预期。

病例介绍

一名男性患者因肩胛骨翼状、手部挛缩和剧烈的躯干痉挛就诊,这些症状使他被迫卧床不起。在保守治疗失败后,这名 18 岁的患者接受了双侧 GPi-DBS 植入。植入后最初的 3 年内主要进行 DBS 参数调整,此后仅进行微小调整。初始设置为左侧接触 3 + 0-,幅度 4.9 V,频率 185 Hz,脉冲宽度 270 μsec;右侧接触 3 + 0-,幅度 2.8 V,频率 185 Hz,脉冲宽度 120 μsec。目前的设置为左侧接触 3 + 2 + 1-,幅度 5.2 V,频率 130 Hz,脉冲宽度 330 μsec;右侧接触 3 + 0-,幅度 3.5 V,频率 185 Hz,脉冲宽度 180 μsec,过去 4 年来一直保持相对不变。统一肌张力障碍评定量表评分显示,肌张力障碍症状明显减轻。

结论

尽管先前的报告表明 GPi-DBS 对肌张力障碍有效,但这是第一项长达 15 年的长期随访报告,显示疾病稳定,表明刺激有效,可能预防疾病进展。该报告再次证实了先前的报告,即建议在永久性肌肉骨骼缺陷出现之前尽早进行手术干预。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验